Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging of Brain Glymphatics in Parkinson's Disease
NCT04768101Phase 1Active, not recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Apr 2020
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of carbon-11 Pittsburgh compound B in Parkinson's disease (PD), sponsored by Vanderbilt University Medical Center. Primary endpoint: Diffusion Tensor Imaging Along Perivascular Spaces. Started Apr 2020; status: active, not recruiting.
02
Drugs
carbon-11 Pittsburgh compound B
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04768101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04768101.